SGC Oxford News

20th October 2009 PLoS ONE launches SGC Collection of innovative articles with 3D interactivity.
The Collection uses the iSee concept, developed in collaboration between the SGC and MolSoft to aid in drug discovery and design.
5th October 2009 Dr. Liz Carpenter joins SGC Oxford to lead the Integral Membrane Protein group.
We are delighted to announce the appointment of Dr. Liz Carpenter as the principal investigator of the Integral Membrane Protein (IMP) group at SGC Oxford.
2nd February 2009 Dr. Paul Beswick Joins SGC Oxford as Epigenetics Project Leader
Paul Beswick has joined SGC Oxford as Project Leader for the International Epigenetics Chemical Probes Consortium - an international SGC-led public-private partnership that will identify molecular probes for twenty five proteins involved in human epigenetic signalling
18th December 2008 International SGC-Led Puplic-Private Partnership Offers New Paradigm for Medicinal Chemistry
The Wellcome Trust is making a £4.1 million investment in a new initiative to generate small molecule inhibitors – "chemical probes" – for 25 proteins involved in epigenetic signalling, and to release these probes into the public domain with no restriction on use.
13th August 2008 SGC PIs Receive Professorships
We are delighted to announce that Stefan Knapp and Udo Opperman have been conferred titles of Professor of Structural Biology and Professor of Molecular Biology respectively, by the University of Oxford Distinctions Committee.
7th April 2008 Dr Tom Heightman appointed as PI of Chemical Biology group
Dr Tom Heightman has joined as the new Principal Investigator for the Chemical Biology group at SGC Oxford
31st January 2008 SGC Oxford has a new Chief Scientist
The Structural Genomics Consortium (SGC) is pleased to announce the
appointment of Dr. Chas Bountra to the position of Chief Scientist of its laboratory at the University of Oxford. Dr. Bountra will lead a team of 65 scientists at the SGC Oxford site and will oversee several new scientific initiatives including the Consortium’s new chemical biology effort. Dr. Bountra has worked in the pharmaceutical industry for twenty years, most recently as the Vice President of Biology at GlaxoSmithKline (UK) within the Neurology Center for Excellence in Drug Discovery.
28th January 2008 SGC Oxford moves into purpose-built new building
17th July 2007 Epigenetics at the SGC in Oxford
9th July 2007 Structural Genomics Consortium Phase II
23rd Oct 2006 SGC Oxford releases experimental data for de-prioritised targets
26th May 2006 SGC participates in the CASP7 protein-structure prediction competition
26th May 2006 SGC Oxford deposit compound screening data in PubChem,
12th September 2005 "Designing for shape", Chemical and Engineering News
SGC Oxford's collaborator, Eric Meggers, uses rigid metal complexes to mimic the shapes of natural products in order to achieve higher potency. Crystallographic structures of these new compounds complexed with PIM1 were solved in-house at SGC Oxford, clarifying the mechanism involved.
June 2005 "Protein Structures Hint at the Shape of Things to Come", Nature
24th May 2005 Structural Genomics Consortium Celebrates First Anniversary with 50 New Protein Structures Ahead of Plan
3rd April 2003 SGC Scientific Committee Dr Tony Pawson wins Wolf Prize
3rd April 2003 Backgrounder: Structural Genomics Consortium (SGC)
3rd April 2003 Anglo-Canadian consortium announce 3D vision
Unravelling the structure of hundreds of human proteins will be the goal of an ambitious £40 million partnership announced on 3 April 2003 by the Wellcome Trust, GlaxoSmithKline and four of Canada's leading research funding agencies.
3rd April 2003 UK-Cdn consortium commits $95-m to international health research project
3rd April 2003 Structural Genomics Consortium launches
1st November 2001 Creating a structural genomics consortium
Article by Alan R. Williamson in Nature.

For more SGC news from our sister-sites, click here.

SGC Oxford | © University of Oxford